Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children
about
Effects of various media on the activity of NXL103 (formerly XRP 2868), a new oral streptogramin, against Haemophilus influenzaeA pilot study of single-dose azithromycin versus three-day azithromycin or single-dose ceftriaxone for uncomplicated acute otitis media in childrenSusceptibilities of Haemophilus influenzae and Moraxella catarrhalis to ABT-773 compared to their susceptibilities to 11 other agentsCurrent management of pediatric acute otitis media.An epidemiological investigation of a sustained high rate of pediatric parapneumonic empyema: risk factors and microbiological associations.Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications.Has antifungal susceptibility testing come of age?Optimizing antibacterial therapy for community-acquired respiratory tract infections in children in an era of bacterial resistance.Hidden epidemic of macrolide-resistant pneumococci.An approach to the diagnosis and management of acute bacterial rhinosinusitis.Macrolides: A Canadian Infectious Disease Society position paper.Single-dose azithromycin for the treatment of children with acute otitis media.Consistency of diagnostic criteria for acute otitis media: a review of the recent literature.Antibiotic choices by paediatric residents and recently graduated paediatricians for typical infectious disease problems in children.Antimicrobial-resistant Streptococcus pneumoniae: trends and management.Improvement rate of acute otitis media caused by Haemophilus influenzae at 1 week is significantly associated with time to recovery.Experimental acute otitis media due to nontypeable Haemophilus influenzae: comparison of high and low azithromycin doses with placeboActivities of two novel macrolides, GW 773546 and GW 708408, compared with those of telithromycin, erythromycin, azithromycin, and clarithromycin against Haemophilus influenzae.Impact of Widespread Introduction of Pneumococcal Conjugate Vaccines on Pneumococcal and Nonpneumococcal Otitis Media.Effect of efflux on telithromycin and macrolide susceptibility in Haemophilus influenzae.Pan-serotype reduction in progression of Streptococcus pneumoniae to otitis media after rollout of pneumococcal conjugate vaccines.Azithromycin use in paediatrics: A practical overview.Near-elimination of otitis media caused by 13-valent pneumococcal conjugate vaccine (PCV) serotypes in southern Israel shortly after sequential introduction of 7-valent/13-valent PCV.A retrospective evaluation of microbiology of acute otitis media complicated by spontaneous otorrhea in children living in Milan, Italy.Establishing criteria for assessment of efficacy of antimicrobial agents in acute otitis media.Assumed versus approved breakpoints.Study design questions in treatment of children with acute otitis media.L’utilisation de l’azithromycine en pédiatrie : un aperçu pratique.Evaluation of antimicrobial treatments in children with acute otitis media in Spain: a pharmacokinetic-pharmacodynamic (PK/PD) approach.
P2860
Q24675058-7FC8A193-6BED-4CF6-9EA7-BEA5E4852EA4Q33772380-739F20E9-0CE0-48F2-8446-B9B470874DA2Q33981117-688F90C5-6714-4A2E-AE1A-FE44BAF4AAA6Q34095298-9A95019B-342A-4B2A-9FF6-C000000B23B4Q34109967-0EABED09-D393-4924-B5C6-C0757EE0F97BQ34498620-F3421081-11DC-49DE-9549-6E92E0DC10F4Q34923038-91DF5043-DCC8-4E3D-8FF5-E8FD6C48E58FQ35692693-BC3F3C00-6A3B-4BF2-9D92-D3037CCAC124Q36009405-495FF2EC-5B76-4160-9A9A-69F1DE88AF33Q36140689-8A49FB24-4879-4521-BA92-6A275BF0EB9AQ36170393-3962069B-CB8F-487F-9804-57B4474E14B9Q36278035-AA8A1801-FFE1-4FAE-AD12-413BD31B1731Q36746116-98296267-DD03-40DD-B31E-D5AF9C68FB05Q36860431-6BE6C827-4D73-4A96-B435-220666E63EE0Q37291341-F6618092-E9BF-4461-BACF-95B8BA80EDF1Q37470304-82EFD4E5-836F-4563-84EB-A30064B3952EQ39652247-8584D153-ABCC-41EF-94FC-1D54C7C4CAE1Q40290446-57604426-5B01-477C-B878-954463EB8EABQ40659753-217BBDE0-FF30-4F3F-81D7-36D3ED829B7EQ41869629-9B968625-7C7E-4A4D-B2D2-A206E7E8DE11Q41987174-BBB69FBC-4872-40DE-9B09-1D9172DF9218Q42151596-B14FC611-6113-412E-8A6C-BBBC4CC68784Q42200242-19FFF4D4-0FAF-456A-9377-D9E3B47BF2F9Q42283847-B6FC5134-A8B9-4DB1-AC04-DA744D4D32F4Q42730027-1CF26775-A659-4271-B723-7E318D79DA06Q42739165-68BE7820-5E9B-402F-994B-68E93CF28B36Q43188427-4AE8DC41-3BFA-434A-957B-E3E15AC9649EQ46499558-733092CC-073C-4512-95FF-1F219C7D2B60Q46908693-D9C8DBF4-5807-4C00-8356-1546976DDEAE
P2860
Bacteriologic efficacies of oral azithromycin and oral cefaclor in treatment of acute otitis media in infants and young children
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Bacteriologic efficacies of or ...... in infants and young children
@ast
Bacteriologic efficacies of or ...... in infants and young children
@en
type
label
Bacteriologic efficacies of or ...... in infants and young children
@ast
Bacteriologic efficacies of or ...... in infants and young children
@en
prefLabel
Bacteriologic efficacies of or ...... in infants and young children
@ast
Bacteriologic efficacies of or ...... in infants and young children
@en
P2093
P2860
P1476
Bacteriologic efficacies of or ...... in infants and young children
@en
P2093
A Leiberman
E Leibovitz
M R Jacobs
P Yagupsky
P2860
P356
10.1128/AAC.44.1.43-50.2000
P407
P577
2000-01-01T00:00:00Z